Showing 2,001 - 2,020 results of 101,376 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( 5 ((w decrease) OR (nn decrease)) ))', query time: 1.52s Refine Results
  1. 2001

    ADAM9 reduction therapy decreased tumor volume by inhibiting cancer cell proliferation. by Che-Ming Liu (102604)

    Published 2013
    “…(c) Immunoblotting assay of ADAM9 expression confirms decreased ADAM9 expression after shADAM9 therapy. EF-1α was used as a loading control (* <i>p</i>≤0.05; ** <i>p</i>≤0.01, Student’s <i>t</i> test). …”
  2. 2002
  3. 2003
  4. 2004
  5. 2005
  6. 2006

    Anti-TGFβ antibody decreased osteoclast numbers and <i>in vitro</i> osteoclastogenesis. by Swati Biswas (73661)

    Published 2013
    “…<p><b>Panel a:</b> Boxplot of number of TRAP positive osteoclasts per millimeter of bone surface in MBA-MB-231 tumor-bearing tibiae, showing significantly decreased osteoclasts upon 1D11 treatment, compared to 13C4. …”
  7. 2007
  8. 2008
  9. 2009

    Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice. by Swati Biswas (73661)

    Published 2013
    “…<p><b>Panel a:</b> Representative H&E sections (5×) of tibia from tumor-bearing mice treated with control antibody (13C4) or anti-TGFβ antibody (1D11). …”
  10. 2010
  11. 2011
  12. 2012
  13. 2013
  14. 2014
  15. 2015
  16. 2016

    Expression of neurotrophins and their receptors was decreased in <i>Slitrk6</i>-deficient inner ear. by Kei-ichi Katayama (257931)

    Published 2009
    “…<p>(A) Real-time PCR analysis of <i>Bdnf</i>, <i>Ntf3</i>, <i>Ntrk2</i>, and <i>Ntrk3</i> in E14.5 inner ear (includes cochlear and vestibular sensory epithelia, and spiral and vestibular ganglia). …”
  17. 2017
  18. 2018
  19. 2019
  20. 2020